A review of poloxamer 407 pharmaceutical and pharmacological characteristics.
about
Cerebral microdialysis for protein biomarker monitoring in the neurointensive care setting - a technical approachNovel formulations for antimicrobial peptidesPain management via local anesthetics and responsive hydrogelsAltered cell mechanics from the inside: dispersed single wall carbon nanotubes integrate with and restructure actinEvaluation of an injectable thermosensitive hydrogel as drug delivery implant for ocular glaucoma surgeryHybrid formulations of liposomes and bioadhesive polymers improve the hypotensive effect of the melatonin analogue 5-MCA-NAT in rabbit eyesEvaluation of the effect of a gamma irradiated DBM-pluronic F127 composite on bone regeneration in Wistar ratFormulation and release behavior of doxycycline-alginate hydrogel microparticles embedded into pluronic F127 thermogels as a potential new vehicle for doxycycline intradermal sustained deliverySustained release of triamcinolone acetonide from an intratympanically applied hydrogel designed for the delivery of high glucocorticoid doses.Stimuli-Responsive Materials for Controlled Release of Theranostic Agents.Developing Xenopus embryos recover by compacting and expelling single wall carbon nanotubes.The effect of poloxamer 407-based hydrogel on the osteoinductivity of demineralized bone matrixBiodegradable nanoparticles composed entirely of safe materials that rapidly penetrate human mucus.Texture and topography analysis of doxycycline hyclate thermosensitive systems comprising zinc oxide.Preparation, characterization, and in vitro permeation study of terbinafine HCl in poloxamer 407-based thermogelling formulation for topical applicationFormulation of immediate release pellets containing famotidine solid dispersionsProlonged-acting, multi-targeting gallium nanoparticles potently inhibit growth of both HIV and mycobacteria in co-infected human macrophages.Single and dual drug release patterns from shellac wax-lutrol matrix tablets fabricated with fusion and molding techniques.Interaction, solubilization and location of p-hydroxybenzoic acid and its sodium salt in micelles of moderately hydrophilic PEO-PPO-PEO triblock copolymers.Poloxamer surfactant preserves cell viability during photoacoustic delivery of molecules into cells.Pluronic F-127 hydrogel as a promising scaffold for encapsulation of dental-derived mesenchymal stem cells.Comparison of silk-elastinlike protein polymer hydrogel and poloxamer in matrix-mediated gene delivery.The effectiveness of poloxamer 407-based new anti-adhesive material in a laminectomy model in rats.A curcumin-loaded liquid crystal precursor mucoadhesive system for the treatment of vaginal candidiasisDoxorubicin and MBO-asGCS oligonucleotide loaded lipid nanoparticles overcome multidrug resistance in adriamycin resistant ovarian cancer cells (NCI/ADR-RES).The influence of modified pluronic F127 copolymers with higher phase transition temperature on arsenic trioxide-releasing properties and toxicity in a subcutaneous model of ratsOptimization and evaluation of astragalus polysaccharide injectable thermoresponsive in-situ gels.The experimental evaluation and molecular dynamics simulation of a heat-enhanced transdermal delivery system.Semisolid matrix-filled hard gelatin capsules for rapid dissolution of amlodipine besilate: Development and assessmentEnhancement of intratumoral cyclophosphamide pharmacokinetics and antitumor activity in a P450 2B11-based cancer gene therapy model.Enhanced and sustained topical ocular delivery of cyclosporine A in thermosensitive hyaluronic acid-based in situ forming microgelsEffect of Poloxamer 407 as a carrier vehicle on rotator cuff healing in a rat model.Thermo-sensitive composite hydrogels based on poloxamer 407 and alginate and their therapeutic effect in embolization in rabbit VX2 liver tumors.Nanoparticles containing insoluble drug for cancer therapy.Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non-erosive reflux disease - efficacy of Esoxx, a hyaluronic acid-chondroitin sulphate based bioadhesive formulation.Effect of a poloxamer 407-based thermosensitive gel on minimization of thermal injury to diaphragm during microwave ablation of the liver.Vaginal mucoadhesive drug delivery systems.Thermosensitive block copolymer hydrogels based on poly(ɛ-caprolactone) and polyethylene glycol for biomedical applications: state of the art and future perspectives.The role of intracochlear drug delivery devices in the management of inner ear disease.Thermosensitive bioadhesive gels for the vaginal delivery of sildenafil citrate: in vitro characterization and clinical evaluation in women using clomiphene citrate for induction of ovulation.
P2860
Q26830132-ECBA1486-CDA5-4830-A21F-D2D7CDA5F8E3Q26991771-1A9CE0DD-D69F-4423-B2C1-566DF44BAA05Q27027236-75055D7A-7B3A-4F79-B237-239EB1DD05F5Q28387306-9F82C94A-D4D3-4E94-9A3D-D613F52A6B23Q28539911-88A64DB7-4BC2-476E-B63A-0B03521C2BBBQ28543935-6F8B3847-4B8F-42CA-8667-4C55A74CE3EAQ28546613-7C6F2C24-4635-40BE-BE5C-D721D7050084Q28748159-5EEED818-FF64-45E3-85BA-32D017BB15A7Q30392675-176289A8-4389-48EC-983F-A3BE3C229832Q30406730-A4C4D8BB-81F7-4686-A6E5-52C0355EDBEEQ30696294-EAF255A2-962D-4C72-96D3-D8CF5D580EE8Q34518854-FDBE8412-91C0-4030-B853-2D1A6CD156A8Q35002405-758F6F4C-4695-434F-AE23-76B4A8451F64Q35058397-0FC9D0BE-D977-45A0-A317-8CB7DD5C7C49Q35100346-0E954F64-4679-477D-AABC-F96F27D4BDACQ35125581-5419DE51-CC77-4660-81DD-AE3B6D859C2EQ35153311-D0F7DE88-CBD9-4DB1-BCBB-BCE2A639AC03Q35166232-44184B79-8E99-4FB0-BD92-3D2EA6DFC54DQ35172745-23F9D8D8-9539-45A7-B047-FC376EC4641FQ35237140-FE928DE7-F03A-4B3A-ACF7-E11E24C99E9FQ35771019-22D9D84B-8E22-4BD4-9408-19B4AE97C463Q35834695-17E1C63F-88F3-4C7F-844B-77834A86952DQ35916384-E4633C35-AACB-45DE-8EEB-8ACF83B2F9EBQ35918840-424899B3-526A-4F0F-B550-DCC9C6A72297Q35982475-1ED9E3BD-A9AE-4DEB-B222-4A1C0FCD7254Q35999080-2809DFAD-001E-416E-BB9E-F2B180614807Q36325294-A989D400-F05B-4A22-8501-39CCECD913DFQ36636584-1EF734DE-E9FE-487D-A624-D3A048641F3EQ36819523-F774DE45-664E-4679-B95B-F1DC15DC332FQ37037051-D3319AFB-CED9-4748-9BED-B63712FD2D75Q37211072-EEC0C0A6-AD15-4A8D-BC46-A2CF37271A78Q37617004-04094B7D-FD02-4DB1-A141-2C36D3F92750Q37687377-79ED0CEB-8C98-410F-9227-8B2A422F3472Q37693046-3D918FD3-4BCA-4FE7-B93A-BF6578DE31B0Q37696562-2421FF5E-D985-49E7-8F0F-83011B62EB02Q37730873-BF30C41A-048E-45AA-A4CE-08985EB586E8Q37945742-DC656C3E-1325-4160-9D3C-6BADA52628B6Q38218890-E5232F45-F30F-44AA-BDBA-58240FFCF16BQ38262931-4C91A8BC-1B7F-4223-8C09-81172BB1D8BDQ38385832-B614430C-C7A8-4A7E-9534-EB7D44F9ED22
P2860
A review of poloxamer 407 pharmaceutical and pharmacological characteristics.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
A review of poloxamer 407 pharmaceutical and pharmacological characteristics.
@ast
A review of poloxamer 407 pharmaceutical and pharmacological characteristics.
@en
type
label
A review of poloxamer 407 pharmaceutical and pharmacological characteristics.
@ast
A review of poloxamer 407 pharmaceutical and pharmacological characteristics.
@en
prefLabel
A review of poloxamer 407 pharmaceutical and pharmacological characteristics.
@ast
A review of poloxamer 407 pharmaceutical and pharmacological characteristics.
@en
P2093
P1476
A review of poloxamer 407 pharmaceutical and pharmacological characteristics
@en
P2093
Gilles Dumortier
Jean Claude Chaumeil
Jean Louis Grossiord
P304
P356
10.1007/S11095-006-9104-4
P50
P577
2006-11-11T00:00:00Z